Hacker News new | ask | show | jobs
by puzzlingcaptcha 957 days ago
I think that's near impossible to achieve with an autologous product. To meet those two goals I think you'd need to have an allogenic product manufactured and QCd in advance in a large batch, which you could thaw and infuse on demand. The problem with that approach is histocompatibility (HLA) matching, but several companies are working on that.
1 comments

thanks for sharing. this is such an impactful space. hopefully someone one day can lower the cost to $10K or ideally $1K.